Comparative Clinical Study of Vidangadi Syrup and Albendazole in Krumi Rog

Pharmaceutico-Analytical study of Vidangadi Syrup in Krumi Rog with special reference to Helminthiasis in Adults: A Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/105004

Enrollment

Registered

2026-02-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B820- Intestinal helminthiasis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Anorexia 2. Abdominal pain. 3. Nausea and vomiting 4. Diarrhoea. 5. Gas, bloating, and indigestion 6. Headache. Itching around the anus. Duration of the disease not more than 1 2 months

Exclusion criteria

Exclusion criteria: 1. Major systemic illness 2. Severe anaemia 3. Fever 4. Severe chronic disease 5. Inflammatory Bowel Disease (IBD) 6. Celiac Disease 7. Chronic liver disease 8. Use of anthelminthic drugs within 4 weeks prior to treatment 9. Pregnancy 10. Lactation 11. Malignancy 12. Allergy to study medication

Design outcomes

Primary

Measure	Time frame
1. To study and prepare the pharmaceutical formulation of Vidangadi Syrup. 2. To analyse the organoleptic and physio-chemical parameters of Vidangadi Syrup. 3. To clinically evaluate and compare the effect of Vidangadi Syrup and Albendazole in Krumi Rog in adults.Timepoint: Follow up on 1st,2nd,3rd and 4th week for 30 days.	—

Secondary

Measure	Time frame
Not applicableTimepoint: Not applicable	—

Countries

India

Contacts

Public ContactDr Vishal Nandurkar

Shri Ayurved Mahavidyalaya ,Nagpur

vishalnandurkar60691@gmail.com9545326229

Outcome results